Body Protection Compound 157, PL 14736. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Days 1-10 loading phase |
500 mcg | daily | 0.1 mL | 10 u | 11 | 5.5 mg |
| Maintenance twice weekly once the response is established |
500 mcg | twice weekly | 0.1 mL | 10 u | 8 | 4 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Low reported | 250 mcg | daily | 0.05 mL | 5 u | 40 doses |
| Commonly reported | 500 mcg | daily during loading | 0.1 mL | 10 u | 20 doses |
| Maintenance | 500 mcg | twice weekly | 0.1 mL | 10 u | 20 doses |
| Approved implant equivalent | 16 mg implant / 2 months | not comparable | Set by body weight — can't be turned into a single amount to draw | ||
A selective alpha-MSH analogue. Approved in some jurisdictions as afamelanotide for erythropoietic protoporphyria, but as a sustained-release implant rather than a reconstituted injection, so the approved dosing does not translate directly. Distinct from Melanotan II, which is less receptor-selective and carries different reported effects.
Buy Melanotan-1Paid affiliate links.
Adding 2 mL of bacteriostatic water to a 10 mg vial gives 5 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for Melanotan-1 run from 250 mcg to 500 mcg, typically daily. This site lists each figure with the source it came from rather than giving a single recommended number.
At 5 mg/mL, a 250 mcg dose is 5 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 40 doses.
Melanotan-1 is graded clinical. Human trial or approved-label dosing has been published for this compound. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Need this on one page to print, screenshot or send?
Make a dose card →Side-by-side with the compounds it is most often weighed against — doses, evidence tier and how each is mixed.
Compounds in the same class, or browse the full catalogue.
The C-terminal tripeptide of α-melanocyte-stimulating hormone, studied for anti-inflammatory activity in colitis and dermatitis mo…
A synthetic fragment of thymosin beta-4, the actin-sequestering protein. Full-length Tβ4 reached human trials for dry eye and card…
Every compound compared in one table: dose range, how often, half-life and evidence tier.